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Type 1 diabetes mellitus (T1DM) is a chronic and potentially life-threatening 
condition affecting the production of insulin, with rapidly increasing incidence 
worldwide. The disease impacts on nearly all domains of life, including the physical, 
social, neurological and psychological. Adequate management of the disease requires 
careful monitoring and self-care to maintain glycaemic control. Executive function 
(EF) refers to a cluster of top-down cognitive processes engaged in the planning and 
completion of goal-directed behaviour allowing an individual to plan their actions, 
contemplate novel challenges, resist temptation and focus attention while avoiding 
distracting stimuli. Young adulthood represents an important developmental stage 
during which robust EF is essential. Previously limited research has explored the 
impact of T1DM on EF specifically within a young adult population. The current 
study recruited a sample of young adults between the ages of 16 and 24 withT1DM 
(n=14) and an age and gender matched control group (n=14) of non-diabetic 
individuals. Groups were assessed on measures of EF while maintaining blood 
glucose levels within a euglycaemic range. The central aims of the study were to 
compare and contrast the diabetic and control group EF performance, and to explore 
the relationship between diabetic related variables and measures of EF. It was found 
that the diabetic group committed significantly more errors than the control group on 
a test of set-shifting ability. It was also found that the relationship between 
performance-based tests of EF and a rating scale measure of EF was unique to each 
group. HbA1c, a measure of longer term glycaemic control, was found to be 
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significantly related to a rating scale measure of EF but not performance-based 
measures. It was also found that mean blood glucose level during assessment was 
significantly related to performance on measures of working memory. Despite a 
limited sample size, the findings suggest that in a young adult population there is 
some evidence that T1DM is related to impairments in certain areas of EF — 
including set-shifting, inhibition and the higher-level construct of problem-solving 
ability. Future research could extend these findings by specifically exploring the 
relationship between trail-making tasks and rating scales of EF, examining the role of 
hot EF in diabetes self-care, and determining the sensitivity of specific EF to subtle 
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Diabetes mellitus is a chronic disease which impairs the normal function of insulin 
with the potential for numerous negative health outcomes for those affected. In 1980, 
global estimates of individuals diagnosed with the disease were 108 million, rising to 
422 million in 2014 (NCD Risk Factor Collaboration). This equates to nearly a 
doubling in prevalence from 4.7% to 8.5% (age standardized). Economically, 
diabetes presents a significant and increasing burden on public health (Zhang et al., 
2010), with estimates of total global healthcare expenditure of 376 billion USD in 
2010, representing 12% of overall health expenditure. This value is projected to rise 
to 490 billion USD by 2030. Demographic shifts have also occurred, with prevalence 
increasing at a greater rate in low and middle-income countries in comparison to 
high-income countries (World Health Organisation, 2016). 
In New Zealand overall prevalence resides at close to 7%, and is more 
common in males (8%) than females (6%). Self-reported prevalence is almost double 
in Maori compared to non-Maori (Ministry of Health, 2016b).  With respect to all 
health loss causes in New Zealand, diabetes has advanced most in rank between 1990 
and 2013—from 16th to 7th among males and from 22nd to 12th among females 
(Ministry of Health, 2016a). 
All forms of diabetes share a common factor in that they affect the body’s 
capacity to produce or use insulin. Insulin is a hormone produced by the β-cells of the 
pancreas responsible for maintaining blood glucose levels (BGL) within a narrow 
range despite the intake of large amounts of food. When food or more specifically 
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carbohydrate is eaten, the secretion of insulin promotes the storage of glucose as 
glycogen into the liver or muscle structure where it can be used for energy (Atkinson, 
Eisenbarth, & Michels, 2014). Insulin also encourages triglyceride (body fat) storage, 
exerting influence on lipid production in the liver, adipose tissue, and fat cells 
(DeFronzo, Ferrannini, Zimmet, & Alberti, 2015). Accordingly, adequate production 
of insulin and the body’s ability to use insulin effectively is essential for maintaining 
blood glucose homeostasis. 
Diabetes is most commonly divided into two disease subtypes: Type 1 
(T1DM) and Type 2 (T2DM; Egan & Dinneen, 2014). T2DM is considerably more 
common, constituting around 90-95% of all diabetes cases. T2DM generally arises 
when the tissues of the body develop resistance to the effects of insulin, often in 
combination with some impairment to insulin production.  Risk factors for 
developing T2DM include: increasing age, obesity and a lack of physical exercise. 
Improvements in the latter two factors can significantly ameliorate the effects of the 
disease process, and generally the administration of exogenous insulin is not required. 
In T1DM, or insulin dependent diabetes, there is an autoimmune initiated 
deterioration of β-cells in the islets of the pancreas which causes a progressive 
decline in the body’s ability to produce insulin (Thrower & Bingley, 2014). 
Subsequently the pancreas may produce little or no endogenous insulin, leaving BGL 
unregulated. The autoimmune damage to the β cells is unable to be reversed, meaning 
the disease process is without cure. In response, the affected individual will generally 
require on-going, regular monitoring of BGLs and administration of exogenous 
insulin to support and maintain healthy levels of blood glucose. Failure to do so can 
lead to severe consequences including ketoacidosis, coma and death (DeFronzo et al., 
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2015).  
T1DM, while only accounting for 5-10% of overall diabetes prevalence, 
constitutes close to 80% of paediatric diabetes diagnoses and is slightly more 
common in males (Borschuck, Everhart, & Everhart, 2015). The peak age of 
diagnosis is around 5-7 years of age or early adolescence, however increasing disease 
prevalence also appears to be accompanied by increasingly younger age of diagnosis 
(van Belle, Coppieters, & von Herrath, 2011). Given the more typical early age of 
diagnosis, T1DM is also sometimes referred to as juvenile-onset diabetes. 
The exact epidemiology of T1DM is unclear, with most current hypotheses 
suggesting some form of gene-environment interaction (Vehik & Dabelea, 2011). 
Proposed risk factors include: genetic vulnerability, diet, body-size, viruses, and 
geographic location. There is increasing evidence to suggest that both maternal diet 
during pregnancy and diet in the early years of life may play a significant role in the 
likelihood of developing islet autoimmunity, a common precursor to T1DM (Norris, 
2010).  
At onset, symptoms of T1DM may include increased thirst, tiredness, 
excessive urination, weight loss, excessive hunger and mood disruption. Diagnosis is 
typically informed by a BGL measurement, either in the fasting state or following an 
oral glucose tolerance test (OGTT). A diabetic individual will usually present with a 
fasting BGL of greater than 7mmol/L, or greater than 11.1mmol/L following an 
OGTT (Diabetes New Zealand, 2016).  More recently it has been recommended that 
HbA1c, a measure of glycated haemoglobin may be a better diagnostic measure. This 
reflects the individual’s glycaemic control over the past two to three months, 
providing a more comprehensive picture of blood glucose regulation over time. An 
 4 
HbA1c level greater than 48mmol/mol is the recommended diagnostic cut-off 
(International Expert Committee, 2009). 
For the individual affected by T1DM, proper management of BGL requires 
considerable monitoring, organisation, planning and commitment. Proper disease 
management will usually involve multiple self-administered daily injections of a 
basal (long acting) insulin, as well as bolus (rapid acting) insulin before or after meals 
to lower BGL to within a healthy range (Diabetes New Zealand, 2016). While more 
recent technological advances have seen increasing use of insulin pumps and 
continuous glucose monitoring — this carries additional cost, is not suited to all 
individuals, and is not without potential for complication (van Dijk et al., 2012). 
Diet and exercise plays an important role in BGL regulation and overall 
diabetes management (American Diabetes Association, 2007).  The inclusion of 
fruits, vegetables, whole-grains, legumes and low fat milk is recommended. To 
ensure the accurate provision of postprandial (after meal) bolus insulin it becomes 
important to monitor the carbohydrate content of each meal (Neupane & Evans, 
2014). This may mean it is easier for the individual to have routine meals with known 
carbohydrate content. In contrast, exercise and physical activity may serve to deplete 
glucose stores, effectively lowering BGL. This may require the consumption of 
additional carbohydrate to counter any glucose depletion and avoid hypoglycaemia 
(low BGL). Maintaining good health and functioning is a complex exercise in 
counter-balancing both the intake and expenditure of energy (glucose), which will 
ultimately determine longer-term health outcomes.  
Chronic poor management of BGL significantly increases the risk of several 
severe health concerns associated with diabetes including retinopathy (eye damage), 
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nephropathy (kidney damage), neuropathy (nerve damage), and cardiovascular 
disease (Atkinson, Eisenbarth, & Michels, 2014). These complications are primarily a 
result of long-term elevated BGL (hyperglycaemia), in which cells are bathed in an 
excess concentration of glucose. Certain cells such as the capillary endothelial cells in 
the retina, mesangial cells in the renal glomerulus, and neurons and Schwann cells of 
peripheral nerves show limited capacity to self-regulate internal glucose 
concentrations and thus are more vulnerable to damage (Brownlee, 2005). As might 
be expected, the development of diabetes related complications has been found to 
significantly reduce quality of life and increase the risk of developing psychiatric 
symptoms such as depression (Alan M. Jacobson et al., 2013; van Steenbergen-
Weijenburg et al., 2011).    
Severe and extended periods of hyperglycaemia can also lead to diabetic 
ketoacidosis (DKA), an acute and life threatening condition that is considered  one of 
the most serious and common complications of T1DM (Perilli, Saraceni, Daniels, & 
Ahmad, 2013). During DKA, excess blood glucose and increased levels of 
counterregulatory hormones cause an overproduction and underutilisation of ketones 
in the body. Unregulated ketones can encourage metabolic acidosis, a lowering of pH 
in the bodily fluids (Kitabchi, Umpierrez, Miles, & Fisher, 2009). DKA can occur 
within a matter of hours, and without intervention can lead to coma and death. 
Recurrent episodes of DKA have been found to increase risk of mortality, particularly 
among young adults who are socially disadvantaged (Gibb, Teoh, Graham, & 
Lockman, 2016). 
While the use of exogenous insulin is essential to regulate BGL, a potential 
side-effect of this intervention is excessively lowering blood glucose concentrations, 
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causing hypoglycaemia (Heller & Chow, 2014). Hypoglycaemia can also occur due 
to missed meals or excess exercise without carbohydrate to compensate. An acute 
episode of hypoglycaemia can present as sweating, tremor, palpitations, confusion 
and drowsiness. As BGLs continue to decline, coma, brain damage and even death 
can occur. With disease duration the likelihood of a severe hypoglycaemic episode 
increases as the body’s physiological defence mechanisms become decreasingly 
sensitive to lower concentrations of blood glucose, meaning an individual may be less 
likely to become aware of the signs of a hypoglycaemia (Snoek, Tibor & Rondags, 
2013). Even low level hypoglycaemic episodes often show an effect on the 
individual’s mood, presenting as agitation, irritability and rapid mood fluctuation.  
Diabetes and cognition. Given that glucose is the primary source of fuel for 
the brain (Heikkilä et al., 2010) it is perhaps unsurprising that T1DM is associated 
with poorer cognitive performance across several domains. These include 
intelligence, attention, processing speed and cognitive flexibility in both children 
(Gaudieri, Chen, Greer, & Holmes, 2008) and adults (Brands, Biessels, de Haan, 
Kappelle, & Kessels, 2005). Gaudieri et al. (2008) conducted a meta-analysis of 15 
studies of paediatric cognitive function between the years of 1985 and 2008 to 
examine the relationship between T1DM and cognition.  
The study included a total of 2144 children, 1393 of which had a diagnosis of 
T1DM. Salient inclusion criteria were: a diagnosis before age 18, a measure of 
cognition administered, and the presence of a control group (at least age-matched). 
Average age of diabetes onset was 6.6 years (range 4.13 -11.18) and average disease 
duration was 5.23 years (range 0.5-8.9).  
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It was found that the diabetic participants performed more poorly than the 
controls on nearly all cognitive measures including: overall cognition, intelligence 
(fluid and crystallised), attention and executive function, speed of information 
processing, motor speed, visual-motor integration and academic achievement.  
Groups did not differ significantly on measures of learning and memory.   
 A meta-analysis by Brands et al. (2005) examined 33 studies between 1980 
and 2004 looking at cognitive function in adults with T1DM.  Salient inclusion 
criteria for studies included: participants over 18 years of age, the presence of a 
control group, and the use of reliable neuropsychological measures administered at a 
normal (euglycaemic) blood glucose level. Compared with non-diabetic control 
participants, the T1DM group demonstrated significantly poorer performance in 
overall cognition, intelligence (fluid and crystallized), speed of information 
processing, psychomotor efficiency, visual and sustained attention, mental flexibility, 
and visual perception. The authors surmised that the primary deficits in T1DM appear 
centred around reductions in both processing speed and cognitive flexibility; a pattern 
of cognitive dysfunction that appears to be similar for both children and adults 
(McCrimmon, Ryan, & Frier, 2012).  
It has been posited that mild cognitive dysfunction may occur as a result of 
impaired neurotransmitter function, potentially arising as a cumulative result of poor 
glycaemic control, or glycaemic fluctuations between periods of hypo- and 
hyperglycaemia. (Northam et al., 1998; Rustad et al., 2013). 
Another theory suggests that rather than a cumulative effect, it is potentially 
the timing of glycaemic events that is most salient, for example during critical 
developmental periods or periods of central nervous system vulnerability (Schwartz, 
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Axelrad, & Anderson, 2014). Both glucose demand and brain volume rapidly 
increase from the early months of life to the age of six; by age 10 glucose usage of 
the brain is twice that of the adult brain. Throughout adolescence significant synaptic 
pruning occurs alongside increasing myelination (Arbelaez, Semenkovich, & 
Hershey, 2013). Given that the onset of T1DM often co-occurs with these structural 
brain changes, and the brain’s reliance on a constant supply of glucose, it follows that 
the effect of a significant glycaemic event may be detrimental during this period.  
There is evidence that disease duration appears to be positively correlated 
with cognitive impairment, with progressive impairments in motor speed, visual and 
verbal memory, executive function and visuospatial performance in some cases being 
observed within 1-3 years of diagnosis (Desrocher & Rovet, 2004). Structurally, it 
has been found that within type 1 diabetics, chronic hyperglycaemia has been 
associated with reduction in whole brain grey matter, while episodes of severe 
hypoglycaemia are associated with reduction in parietal/occipital white matter 
(Perantic et al., 2011). Both structural and functional changes to the brain have been 
observed in older type 1 diabetics independent of cardiovascular risk factors and 
diabetic complications (Hughes et al., 2013), suggesting the disease may exert an 
independent neurodegenerative effect.  
A series of studies which specifically demonstrated cognitive decline over 
time were conducted by Northam et al. (1998). The initial study compared the 
cognitive performance of 129 children (age range 3-14 years) three months after 
receiving a diagnosis of T1DM against a control group matched on age and sex. At 
baseline testing it was found that the neuropsychological profile and general 
intelligence of those with T1DM was not different to that of the control group.  
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The groups were retested two years later, at which point the diabetic group 
were found to perform significantly poorer in domains of visuospatial ability, 
vocabulary, processing speed and learning. Those within the diabetic group exhibited 
less positive changes to their full-scale IQ score over the two years than the control 
group, particularly if developing diabetes prior to age five (early onset). 
In a follow-up study Northam et al. (2001) compared children from their  
original study six years post-diagnosis, on measures of intelligence and 
neuropsychological functioning (n=90, T1DM and n=84, control). Children with 
T1DM showed significantly lower verbal and full-scale IQ, and reduced attention, 
processing speed, and executive skills when compared to the control group. 
Attention, processing speed and executive skills were most affected in children who 
had developed diabetes prior to the age of four.  
However, not all studies have demonstrated an impact of T1DM on cognitive 
ability.  Alan M. Jacobson et al. (2007) found limited evidence of cognitive decline in 
a large sample (1144) of individuals (mean age =27 at entry) with T1DM that were 
followed over a course of 18 years, despite approximately 40% of the sample 
experiencing episodes of severe hypoglycaemia. The study tested the sample group at 
baseline and at 18 years on measures of problem solving, learning, memory, 
attention, visuospatial ability, motor speed and psychomotor and mental efficiency. It 
should however be noted that only a small proportion of individuals in this study 
experienced early onset of the disease. 
To summarise, diabetes mellitus, specifically T1DM, is a chronic and 
potentially life-threatening condition with rapidly increasing incidence worldwide. 
The disease impacts on nearly all domains of life, including the physical, social, 
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neurological and psychological. Adequate management of the disease requires careful 
monitoring and adjustment to maintain a balance between hypo- and hyperglycaemic 
states. Failure to do so can have acute and serious effects, while even minor 
deviations over time may result in longer term impairment. Several studies suggest 
cognitive impairment is a common correlate of T1DM; however it is unclear whether 
this is purely a function of poorly managed BGL, disease pathology, or a combination 
of both. The current study now focusses on a specific area of cognition, that of 
executive function, and its relationship to T1DM. 
Executive Function 
Executive function or functions (EF or EFs) refers to a cluster of top-down 
cognitive processes engaged in the planning and completion of goal-directed 
behaviour (Diamond, 2013). According to Lezak (1982), EFs “are at the heart of all 
socially useful, personally enhancing, constructive, and creative activities” (p.281). 
EFs allow an individual to plan their actions, contemplate novel challenges, resist 
temptation and focus attention while avoiding distracting stimuli.  
The executive processes that contribute to EFs are associated with a complex 
range of interrelated neural networks within the prefrontal cortex (PFC) (Stuss & 
Knight, 2002). However the function of the PFC itself is interrelated with nearly 
every other region of the brain, meaning structural damage outside of the PFC may 
still result in some executive dysfunction. It also appears that reliance on the PFC 
may change over time, with EFs in elderly individuals drawing on a broader range of 
brain regions in comparison to young adults (Spreng, Wojtowicz, & Grady, 2010). 
While PFC integrity is important for stable and robust EFs, it is not the only region 
upon which EF relies.  
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A number of neuropsychological models of EF have been proposed to date, 
however no model has received universal acceptance. Some early models 
conceptualised EFs as existing within a unitary control system such as the “central 
executive” (Baddeley, 1986) or the “supervisory attentional system” (Norman & 
Shallice, 1986). However these models generally experienced difficulty accounting 
for phenomena such as the poor correlation between measures of executive processes 
and the absence of global executive “dysfunction” (Anderson, 2008).  
More recent research suggests EFs constitute multiple separate yet interrelated 
cognitive control processes (Baddeley, 1998; Sylvester et al., 2003). These processes 
are ultimately responsible for the control and organisation of cognitions, behaviour 
and emotions. Broadly speaking, all conceptual models suggest some or all of the 
following components as central to EF: attention, inhibition, initiation of activity, 
working memory, cognitive flexibility, planning and problem solving (Anderson, 
2008). 
Miyake et al. (2000) and Lehto, Juujärvi, Kooistra, and Pulkkinen (2003) 
suggest there are potentially three core EFs: inhibition (of automatic responses), 
updating and monitoring of information in working memory, and mental set-shifting 
or cognitive flexibility. These serve to provide the foundation for more complex 
higher order EFs including reasoning, problem-solving and planning (Diamond, 
2013). 
Inhibition refers to both behavioural inhibition; self-control or avoiding 
responding impulsively, and also cognitive inhibition or interference control recruited 
when selective attention is required, allowing for sustained and focussed attention. 
The “updating” and monitoring of working memory (WM) refers to the sorting of 
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incoming information by relevance to a required task, then revision and replacement 
of old redundant information held in WM with new relevant information. In short; it 
is the dynamic and active manipulation of information held in WM. Cognitive 
flexibility or “shifting” refers to the ability to configure mental resources to switch 
between various cognitive tasks (Monsell, 2003). This requires intentional 
discrimination between procedural schemas or task sets relative to a desired or 
dominant goal. 
A further distinction is the classification of EFs into “hot” or “cool” executive 
processes (Zelazo & Muller, 2010). Cool executive processes refer to those that are 
purely cognitive, recruited when approaching abstract or decontextualized problems; 
effortful attention and prepotent response inhibition are examples of these. Hot 
processes are those associated with emotional or affective regulation and decision 
making, for example in tasks requiring delayed gratification (Kim, Nordling, Yoon, 
Boldt, & Kochanska, 2013). 
Executive function and development. EF is essential to almost every aspect 
of life including mental and physical health, academic performance, career success, 
and social ability (Diamond, 2013). As EFs are typically associated with several areas 
of the PFC, they develop throughout childhood and adolescence, reaching maturation 
in early adulthood (Rossi et al., 2013).  Generally, EFs exhibit progressive linear 
development until around 22 years of age, although some particular EFs may peak 
before others (Taylor, Barker, Heavey, & McHale, 2013). The progressive 
development of EFs is believed to be a result of increasing myelination of axons in 
the PFC which continues through adolescence, in particular cortico-cortical and 
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cortico-limbic neural circuits. This allows for a significantly improved speed of signal 
transmission between neurons (Choudhury, Charman, & Blakemore, 2008).  EFs are 
observed to decline in later life, associated with volumetric shrinkage of the PFC 
(Raz, Gunning-Dixon, Head, Dupuis, & Acker, 1998).  
Executive function and the young adult. Adolescence and early adult life is 
a period of particular vulnerability to impaired decision making, with the potential for 
life-long negative impacts. Individuals in this developmental period are more likely to 
engage in substance abuse, risky sexual behaviour and breaking of societal norms 
(Crone, Bullens, van der Plas, Kijkuit, & Zelazo, 2008). The decision to engage in 
these behaviours is often made in spite of explicit knowledge of potential negative 
consequences. This increase in risk-taking behaviour is believed to be partly a result 
of rapid sub-cortical development, which exceeds the concurrent cortical capacity for 
regulation and inhibition (Romer et al., 2011). Put simply, the adolescent is likely to 
experience strong emotional drives without the required capacity for cognitive 
regulation of these emotions. 
There is a general pattern of reduced risk-taking behaviour as the young 
person matures into early adulthood, correlating with normal cortical development, 
but in which good EF appears to play a significant mediating role (Brand & 
Schiebener, 2013). In fact, EF appears to mediate risk-taking and facilitate decision 
making throughout the lifespan, in both children (Lahat et al., 2012) and older adults 
(Menon, Jahn, Mauer, & O'Bryant, 2013). Schiebener, García-Arias, García-
Villamisar, Cabanyes-Truffino, and Brand (2015) suggest than on average, children 
and adolescents make the most high-risk decisions, with potential for the most severe 
 14 
consequences, with middle adulthood representing the most stable decision making 
period.  
A study conducted in New Zealand examined risk-taking behaviour and EF in 
a community sample of young people between the ages of 13 and 22 (Pharo, Sim, 
Graham, Gross, & Hayne, 2011). The authors found that in this sample, poorer results 
on neuropsychological tests of EF correlated with increased real-world risk taking 
behaviours. Specifically, deficits in the area of inhibitory control may make 
adolescents and young adults more vulnerable to putting themselves at risk. 
EF, while a construct that is not always consistently defined, is shown to 
constitute an incredibly important range of cognitive functions that allow an 
individual to plan, strategize, inhibit, problem-solve and maintain control over their 
behaviour. In many ways they separate the adult mind from that of the child, 
representing the higher order cognitive functions that enable one to independently 
function in the world. These functions develop rapidly during the course of 
adolescence and into young adulthood and appear most stable in middle-adulthood, 
before declining in old age.  The role of well-developed EFs is particularly salient for 
the young adult, as this represents a developmental period in which there is a greater 
likelihood of risk-taking behaviour. Any factor that threatens to impair EF therefore 
places the young adult at greater risk, and warrants careful examination. 
Diabetes and executive function. As discussed, there is evidence T1DM may 
exert a significant impact on several domains of cognition, even after a relatively 
short disease duration. Of relevance to the current study is the specific impact of 
T1DM on EF, with a particular focus on the young adult.  
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A study by Rovet and Alvarez (1997) explored intelligence and components 
of EF in a group of 103 children and adolescents with T1DM (age range 9.3-18.3 
years) and compared their performance to a control group approximately matched on 
age and gender. Each group shared an approximately even gender split. On average 
participants in the diabetic group had been diagnosed for 6.8 years (range 2-14 years) 
.The authors chose to focus on areas of EF relating specifically to attention, and 
included the following relevant measures: Stroop Test, Modified Matching Familiar 
Figures Test (MMFFT), Trail Making Test, Visual Search Test and the Wisconsin 
Card Sorting Test (WSCT). Transient glucose levels were not regulated prior to 
assessment; BGL was however monitored at five intervals throughout the testing 
process.  
The authors divided the attentional process under examination into 
subcomponents: Focus, Select, Inhibit, Suppress, Shift and Sustain. The diabetic 
group only differed significantly from the control group on ‘Select’, which was 
derived from mean error scores on the MMFT. This task requires the participant to 
select the correct match to a presented card (target) from a range of response 
alternatives. The authors concluded that the result was primarily a function of the 
performance of those participants who had been diagnosed prior to the age of six; 
however length of diagnosis was not related to any aspect of attention. This suggests 
early-onset diabetes may exert a more significant impact on EF than disease duration.  
The authors found that a history of hypoglycaemic seizures was associated 
with poorer performance on the Select, Focus and Inhibit attentional components. 
They also found higher BGL during testing was associated with a more impulsive 
responding style on a computer based vigilance test. Interestingly length of diagnosis 
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or HbA1c level was not found to correlate with any aspect of attention/EF. 
The findings of Rovet and Alvarez (1997) have a several potential limitations.  
The test on which a between-group difference was observed, the MMFT, was initially 
developed as a measure of impulsivity vs reflectiveness, suggesting the more 
impulsive individual would be less careful and more likely make more errors in their 
selection (Egeland & Weinberg, 1976). Although the authors did not find a 
correlation between transient or acute BGLs and errors on the MMFT, fluctuations in 
transient BGL has been found to affect performance on other tests of impulsivity and 
attention (Topitsch, Schober, Wurst, & Kryspin-Exner, 1998).  
There is also some debate as to whether the MMFT is more of an ability test -
— reflecting intelligence more so than any specific cognitive component (Weijers, 
Wiesbeck, & Böning, 2001).  While the groups did not differ significantly on overall 
IQ, intelligence was not controlled for in their analysis. IQ has been shown to 
correlate with some measures of EF (Friedman et al., 2006), suggesting controlling 
for this variable is important when assessing EF.  
A more recent study by Ly, Anderson, McNamara, Davis, and Jones (2011), 
compared the performance of a group of 33 young people (mean age 19.3 years) with 
early-onset T1DM, to a matched control group (n=34, mean age 19.5) on measures of 
memory, intelligence, EF and mood. The diabetic participant sample represented a 
subset of an original study group (n=84) that had been monitored for approximately 
16 years, since time of diagnosis. The authors therefore had access to reliable data on 
HbA1c at diagnosis and a history of glycaemic events, including seizures, coma and 
microvascular complications.  
The primary measure of EF used was the Wisconsin Card Sorting Test 
 17 
(WCST), a measure of set-shifting ability, concept formation and problem solving in 
response to feedback. BGLs were maintained between 4-15 mmol/L throughout 
testing. The authors found no difference between the groups on measures of IQ, 
memory or reported emotional difficulties. On the WCST, the diabetic group subjects 
completed fewer categories (p=.022) and committed more perseverative errors 
(p=.002) than the control group. The authors concluded that the presence of diabetes 
did not appear to impact on an individual’s memory, general intelligence or emotional 
difficulties however did potentially result in minor deterioration in EF. The authors 
also found the presence of early severe hypoglycaemia events were associated with 
poorer EF in the diabetic group, however this group subset was relatively small 
(n=6).  
As the WCST is believed to assess a range of executive domains, it 
considered a good overall measure of general EF (Mitrushina, 2005). However a 
general measure is not likely to be as informative as a more comprehensive test 
battery, particularly for a construct as diverse as EF.  
The two studies described above provide some insight into the potential 
relationship between EF and T1DM in the young adult. However both share 
limitations in the scope of EF they explore; the former focused on attentional 
components with limited exploration of set-shifting/cognitive flexibility or updating 
of working memory, and the latter using only one more general measure of EF.  
The former study also examined EF in a primarily adolescent rather than young adult 
age range, and did not attempt to control BGL during assessment. Given the varied 
timeline of EF development and impact of acute changes in BGL on cognition, this 
represents a potential limitation to the generalisability of these findings. 
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Summary and Research Aims 
 Several topics central to the current study have been discussed including: 
T1DM pathology, impact and management; the effect of diabetes on cognition, and 
specifically its effect on EF; EF and development, and the importance of EF for the 
young adult. The young adult with T1DM as such provides a complex intersection of 
a developmental stage and a disease process. Developmentally, this is a life period 
where risk-taking is more likely, and the consequences of these risks are potentially 
serious and long-lasting. Young adults are often for the first time trying to navigate 
many new and complex life tasks including relationships, employment, learning to 
drive, managing finances, and developing a stable identity.  
T1DM potentially impacts upon this developmental stage by its effects on 
cognition and specifically on EF, a set of complex higher-order cognitive processes 
particularly essential to helping the young-adult safely navigate the world around 
them, implicated in inhibition, planning, working memory and cognitive flexibility. 
For the young adult with diabetes, there is an additional burden of the many tasks of 
disease management, all of which require effective monitoring, planning and 
behavioural regulation. Poor disease management at best dysregulates one’s energy, 
mood and cognition, and at worst can be fatal. Accordingly, the young-adult with 
T1DM represents a particularly vulnerable population, who may be at increased risk 
of impairments in EF, which may have serious outcomes for both disease 
management and effective and safe functioning in the world. 
The majority of previous studies have explored cognition more broadly within 
the type 1 diabetic population, many of which including some measures of EF within 
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their scope. However, few studies have chosen to focus specifically on EF, or 
specifically examine a young adult population. There is also adequate research that 
has shown the acute effects of altered BGLs on EF, but the literature is inconclusive 
regarding whether T1DM by its very presence exerts an influence on EF or if poor 
diabetes management and/or glycaemic events during sensitive stages of development 
must occur before any significant effect is observed.  
The current study intends to explore some of these gaps in the literature by 
specifically examining EF in a population of young-adults diagnosed with T1DM. 
The two central research aims are: 
 To examine any differences between a sample of young adults with and 
without T1DM in the area of EF 
 To examine the relationship between diabetic related variables including 
HbA1c, time since diagnosis and age of diagnosis, and EF in a sample of 




The current study used data gathered for a larger parent project looking at the effects 
of blood glucose levels on driving behaviour and executive functioning in young 
people with T1DM. Additional data was collected from a non-diabetic control group 
for comparison purposes. Ethics approval for the parent project was obtained from the 
University of Waikato’ School of Psychology and the Health and Disability Ethics 
Committee, reference number 14:80 and Ref 14/CEN/181.  
The current study adhered to the parent project protocol, did not involve the 
diabetes service and did not require manipulation or testing of blood glucose 
therefore ethics approval was granted under the existing ethics application. This was 
approved by the School of Psychology Research and the Ethics Committee, 
University of Waikato. 
Participants 
Diabetic group. Contact details for potential participants for this group were 
extracted from the Waikato Regional Diabetes Database. All individuals were located 
within the Waikato region, and used the Hamilton clinic as their primary point of 
contact with the Diabetes Service. Inclusion criteria were age (16-24 years) and a 
diagnosis of T1DM. N=99 individuals were found to meet the inclusion criteria, the 
large majority of which were invited to participate in the study. Following contact 
initially by mail and then by phone, individuals wishing to participate were required 
to meet additional inclusion criteria which were: a diagnosis of T1DM of greater than 
6 months; a full or restricted drivers licence; and driving of a vehicle at least four 
 21 
times per week. Exclusion criteria were: pregnancy; regular use of illicit substances; 
an episode of DKA in the last 48 hours or an episode of documented severe 
hypoglycaemia requiring assistance in the previous 24 hours.   
DKA and diagnosis of diabetes. DKA is a serious condition arising from 
decreased circulating insulin, insulin resistance and increases in counterregulatory 
hormones, usually lasting around 48 hours (Jefferies, 2008). Pathophysiology 
typically involves an increase in ketone production, severe hypoglycaemia and 
dehydration. Individuals with T1DM are at increased risk of DKA, and it is the 
leading cause of diabetes-related mortality amongst children and adolescents.  
 In New Zealand, diagnosis of diabetes requires a fasting blood glucose level of 
≥ 7 mmol/L, or a blood glucose of ≥ 11.1 mmol/L following an oral glucose tolerance 
test (OGTT) or random glucose test (non-fasting) (Diabetes New Zealand, 2016). 
Diagnosis is typically precipitated by an individual becoming symptomatic (polyuria, 
excessive thirst, weight loss, lethargy) and presenting to their health practitioner, or 
an episode of DKA requiring medical intervention.  
Control group. Participants for this group were primarily recruited through 
flyers located on the University of Waikato campus, a University internet noticeboard 
and a database of individuals previously consenting to research at the University of 
Waikato (see Appendix A). Contact details for the researcher were provided and 
interested individuals were asked to make contact directly via phone or email. For 
this group, a diagnosis of diabetes (all types) became part of the exclusion criteria, 
while all other criteria were maintained as per the diabetic group. Attempts were 
made to recruit participants for the control group matched to the diabetic group on 
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age and gender. 
Sample characteristics. The sample characteristics for both diabetic and 
control groups can be found in Table 1.Total sample size was 28 participants, the 
majority which were male (n=20), and identified as New Zealand European. Mean 
age at assessment was similar for both groups with the control group being on 
average 1.3 years older (t(26) = -1.89, p=.07).  
 The large majority of diabetic participants had been diagnosed after the age of 
five, with mean age of diagnosis being 11.3 years, and a mean time since diagnosis of 
eight years. Eight of the participants had experienced at least one episode of DKA. 
The mean body mass index (BMI) for the diabetic group is considered to be within 
the normal range (Ministry of Health, 2009). HbA1c, a measure of longer term 
glycaemic control varied markedly, ranging from 47 to 130 mmol/mol. The mean 
value for the group of 80.4mmol/mol is considered very high, with a suggested 
healthy value of 53 mmol/mol (Diabetes New Zealand, 2016). 
 Groups were relatively well matched on mean estimated IQ (t(26) = -.56, p 
=.58) as well as current reported symptoms of anxiety and depression (t(26) = -.21, p 
=.84, and t(26) = -1.75, p =.09, respectively) as measured by the Hospital Anxiety 
and Depression Scale (HADS). The mean HADS scores for both anxiety and 
depression for each group is considered to be in the normal range (Snaith & 
Zigmond, 1994).  
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Table 1 







Participant characteristics     
Male, n (%) 10 (71.4) 10 (71.4) 
Age (years), M (min/max) 19.3 (17-23) 20.6 (18-23) 
Ethnicity, n (%) 
a     
New Zealand European 14 (100) 13 (93) 
Maori 1 (7) 2 (14) 
Other 1 (7) 4 (28) 
Diabetic related variables     
BMI, M (min/max) 23.1 (18-29) NA NA 
HbA1c (mmol/mol), M (SD) 80.4 26.7 NA NA 
Age at diagnosis (years), M (SD) 11.3 (4.2) NA NA 
Time diagnosed (years), M (SD) 8.0 (5.1) NA NA 
Early onset (<5 years) n (%) 2 (14.3) NA NA 
Previous episode of DKA 
(participants), n (%) 
8 (57) NA NA 
IQ and mood variables, M (SD)     
Estimated IQ 114 (10) 116 (10) 
HADS Anxiety 6.1 (3.3) 6.4 (4.1) 
HADS Depression 2.1 (2.1) 3.6 (2.4) 
Note: 
a 
Participants were able to select more than one ethnicity. NA = Not 
applicable/available. BMI = body mass index. HADS= Hospital Anxiety and Depression 







A range of psychometric measures were used for both groups which are 
described in detail below. These included performance-based tests and 
questionnaires. Measures were chosen in an attempt to cover a range of components 
of EF, employing both verbal and nonverbal tasks. We also obtained a number of 
biomedical measures from the diabetic group. All participants in the study provided 
demographic and general medical information via a questionnaire, including any 
current or historical medical issues and hospital admissions (see Appendix C). 
Executive Functioning 
Cogstate (http://www.cogstate.com) is a computerized test battery providing 
reliable and valid computerised touch screen assessment of cognitive function 
including psychomotor performance, attention, memory, and executive functioning. 
Cogstate offers a number of individual tests, which can be put together to form a test 
battery. All tests are designed for repeated administration, are brief to administer, and 
show minimal learning effects. A computerised test format was deemed appropriate 
given that the study population would likely be familiar with media devices. All 
Cogstate tests were administered on a touch-screen tablet, with the participant using a 
stylus and letter keys to complete the tasks. A summary of the six tests administered 
can be found in Table 2 with a description provided below. Each test is preceded by a 
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Timed Chase Test (TCT). This test assesses a person’s visual motor function 
and familiarises the participant with the Groton Maze environment. Using the touch 
screen participants “chase” a target on a grid as quickly and accurately as they can 
over the course of a single 30 second trial. 
Groton Maze Learning Test (GMLT). This test uses a maze learning 
paradigm to assess executive function and spatial problem solving. Using a grid, 
participants attempt to make their way through a hidden maze, to get from the 
identified start to finish receiving trial and error feedback. Once they have completed 
the maze, they repeat the maze trying to recall the pathway they have previously 
completed. Five consecutive trials are administered over a single session. 
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One Back Test (OBT). This test assesses working memory and attention. 
Participants are shown a card and participants have to indicate if the card shown is the 
same as the previous card. Primary outcome measure is the log10 transformed 
reaction time for correct responses, indicating speed of performance. A lower score 
indicates a better (faster) performance.  
Two Back Test (TBT). This test also assesses working memory and attention. 
During this test the participant is shown a card on a screen and has to decide if the 
card is the same as the card that was shown two cards ago. Primary outcome measure 
is the arcsine proportion of correct responses indicating accuracy of performance. A 
higher score indicates a better (more accurate) performance.  
Set-Shifting Test (SST). This test assesses executive functioning and spatial 
problem solving. Using the computer screen, a card is presented (colour or number) 
and the participant has to guess whether the card is the “target” card, and receive 
auditory feedback as to whether they have guessed correctly. A series of cards are 
then presented and the target stimulus changes dimension, forcing the participant to 
relearn the new target. Multiple shifts are made through the assessment. Primary 
outcome measure is total number of errors made over five rounds indicating accuracy 
of performance. A lower score indicates a better performance. 
Groton Maze Learning Test - Delayed Recall (GMLTDR). For this test the 
participant is provided with a single trial in which they are required to recall the 




Delis Kaplan Executive Function System (D-KEFS;Delis, Kaplan, & 
Kramer, 2001). The D-KEFS is a battery consisting of nine subtests designed to 
assess various components of executive functioning. The measure was normed on a 
representative sample from the U.S population, of healthy individuals ranging in age 
from 8-89 (N=1750). There is research support for the general validity and reliability 
(internal consistency and test-retest) of the D-KEFS (Delis, Kramer, Kaplan, & 
Holdnack, 2004). Each subtest is presented in an interactive game-style format, and 
were administered by the examiner.  Similar to the core components of EF suggested 
by Miyake et al. (2000), a factor analysis of the D-KEFS by Latzman and Markon 
(2010) identified three factors: conceptual flexibility, monitoring and inhibition. Two 
D-KEFS subtests were administered as detailed below, both most strongly loading on 
the inhibition factor.  
Both subtests are timed tasks with primary outcome measures being 
completion time (seconds) and errors (n). Completion times are converted to scaled 
scores (M=10; SD=3). 
Colour-Word Interference Test (CWIT). This measure consisting of four 
conditions is primarily intended to assess the capacity for one to inhibit an automatic 
verbal response when required to name a discrepant coloured patch. The first two 
conditions provide a baseline measure of time to name coloured patches and time to 
read colour name words (for example “yellow”) respectively. In the third condition, 
the participant is asked to inhibit reading the colour word names while naming the 
colour. In the fourth and final condition the participant is asked to switch between 
naming the colour and reading the word. This measures both inhibition and cognitive 
flexibility. For each condition, completion time in seconds is used to generate an age-
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corrected scaled score (M=10; SD=3). The current study examined data from 
condition three and four: colour-word inhibition (CWI) and colour-word inhibition 
switching (CWIS) respectively. 
Trail Making Test (TMT).This test contains five conditions which assess 
visual scanning and attention, flexibility of thinking and working memory. The 
primary EF task used for the current study was condition four, the number-letter 
switching (NLS) task which is a measure of cognitive flexibility or set-shifting 
ability. The remaining four conditions help to provide normative data for cognitive 
processes that contribute to the switching task. They consist of tasks of visual 
scanning, number sequencing, letter sequencing and motor speed. The completion 
time for each condition (seconds) is converted to an age-corrected scaled score 
(M=10; SD=3).  
General Cognitive Ability 
Wechsler Abbreviated Scale of Intelligence – Second Edition (WASI-II; 
Weschler, 2011). This measure is a validated four subtest measure of cognitive ability 
and has been widely used in clinical and research settings. The WASI-II 
standardisation sample was drawn from a nonclinical, national, stratified sample of 
the U.S population aged 6 – 90 (N=2300). To reduce test administration time, only 
two subtests were administered: Matrix Reasoning and Vocabulary. These subtests 
were selected in accordance with WASI-II protocol as a valid abbreviated version of 
the test. Each subtest generates a T-score (M=50, SD=10), which can be converted to 
a scaled score (M=10, SD=3) and contributes to a composite or Full Scale-IQ (FSIQ) 
score (M=100, SD=15). This assessment was used to provide an estimate of IQ for 
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each participant as there is evidence that intelligence may correlate with some 
components of EF (Ardila, Pineda, & Rosselli, 2000). This ensured any potential 
influence of IQ could be considered when examining EF. 
Matrix Reasoning. This subtest consists of 30 picture items which each 
require the participant to correctly select the required part or symbol to complete an 
incomplete matrix or series. This subtest is intended to reflect several areas of 
cognition including: fluid intelligence, broad visual intelligence, classification and 
spatial ability, knowledge of part-whole relationships, simultaneous processing and 
perceptual organisation. 
Vocabulary. This subtest consists of 28 word and 3 picture items. The 
participant is required to provide a definition for the word item or to name the picture 
item. Word items are presented both visually and orally. This test is intended to 
measure word knowledge and verbal concept formation. 
Self-Report Measures 
Behavior Rating Inventory of Executive Function - Self-Report (BRIEF-SR; 
Guy, Isquith, & Gioia, 2004).This is a self-administered rating scale measure of 
executive functioning, designed for young people aged 11 – 18 years. The measure 
has 80 items and assesses a young person’s ability to complete tasks which target 
several domains of executive functioning, including organising, planning and 
attention. The participant indicates how frequently specific behaviours are a problem 
on a three-point Likert Scale; 1=never, 2=sometimes, 3=often. Table 3 provides an 
overview of the measure’s composition.  
 Eight clinical scales contribute to two index scores and an overall composite 
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score. Responses to the BRIEF–SR are converted into T-scores (M = 50, SD = 10), 
with higher scores indicative of poorer EF. Generally T-scores above 65 are 
considered clinically significant, however scores between 60-64 may be considered 
“mildly elevated”. In the standardization sample, measurements of internal 
consistency ranged from .73–.96, and test–retest correlations from .59–.89.  
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Hospital Anxiety and Depression Scale. (HADS;Zigmond & Snaith, 1983). 
This is a 14 item brief screening instrument for anxiety and depression. Screening for 
anxiety and depression was important as it may affect participant’s performance on 
the cognitive and neuropsychological tests.  The HADS has good validity and 
reliability and has been used extensively in other research studies, with both clinical 
and non-clinical populations (Kjærgaard, Arfwedson Wang, Waterloo, & Jorde, 
2014). Good internal consistency has been demonstrated with a Cronbach’s α = .82 
and .77 for anxiety and depression scales respectively (Crawford, Henry, Crombie, & 
Taylor, 2001). Scores for anxiety and depression each range from 0 to 21 and are 
classified as follows: normal 0–7, mild 8–10, moderate 11–14, and severe 15–
21.  Each item is given a score between 0-3 based on symptom frequency, with 3 
being the highest.  
Biomedical – Diabetic Group Only 
HbA1c. This is a measure of glycated haemoglobin which indicates average 
plasma glucose concentration over the past four to six weeks. A Siemens Healthcare 
Diagnostic DCA analyser was used to assess HbA1c from a blood sample obtained 
via a finger prick. This device is checked for quality assurance by the Waikato 
Hospital Laboratory, an accredited laboratory service, once per month. The DCA 
analyser automatically provides all calculations, measures automatically and was 
quality controlled every 24hrs by a trained user. Unit of measurement is mmol/mol. 
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Blood glucose. A Stat Strip Glucose Meter was used for all blood glucose 
measurements, taken via a finger prick blood sample of at least 1.2 microliters. This 
device is checked for quality assurance by the Waikato Hospital Laboratory, an 
accredited laboratory service, once per month. A trained user ensures quality control 
every 24hrs. Unit of measurement is mmol/L. 
Body mass index (BMI). This provides a general measure of tissue mass by 
comparing an individual’s height against their weight. Height and weight 
measurements were taken by a diabetes nurse using clinic measures based at the 
Diabetes Service. Units of measurement were metres and kilograms respectively. 
BMI was calculated using the following formula: weight in kilograms/height in 
metres squared. Unit of measurement is kg/m2. 
Medical information. Additional medical information was collected by the 
research nurse directly from the participant’s medical record. This included: age of 
diagnosis, length of diagnosis, insulin delivery device and management regimen, 
hospitalisations for diabetes-related issues, additional medical diagnoses, and 
diabetes-related complications.  
Design  
 Some data was obtained from a parent study in which the diabetic participants 
were assessed under euglycaemic and hyperglycaemic conditions. The current study 
focuses solely on data collected in the euglycaemic condition as a basis for 
comparison with the control group. Any information about the hyperglycaemic data 
collection is included only for clarification of research design. Table 4 outlines the 
assessments and order of administration. All diabetic group data collected for the 
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current study was obtained in the euglycaemic condition, aside from the BRIEF-SR.  
 
Table 4 














 Cogstate Cogstate 
a 
Blood glucose levels were also measured every hour and at conclusion of assessment 
b
 BRIEF-SR was administered to the diabetic group in the hyperglycaemic condition 
 
Diabetic Group. For the diabetic group a within-group cross over design was 
used, each participant taking part in two assessments spaced approximately 2 weeks 
apart, one in the euglycaemic condition and one in the hyperglycaemic condition. The 
euglycaemic condition was specified as a BGL between 4.0mmol/L – 9.4mmol/L. 
 In the first research session participants were assigned to either of the two 
conditions. To minimise order effects, participants were alternately assigned to a 
condition depending on recruitment order. This process operated independently for 
both males and females, meaning both the first female and first male participants 
started in the euglycaemic condition while the second participant of each gender 
started in the hyperglycaemic condition, and so on. The remaining condition was 
completed in the participant’s second research session. 
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Control group. The control group received a single administration of the 
same psychometric measures as the diabetic group. Biomedical information was not 
collected for this group. In a group of healthy adult volunteers Freckmann et al. 
(2007) recorded peak postprandial BGL of up to 9.3mmol/L occurring around 50 
minutes after a main meal. This suggests that at peak, the BGL of a healthy individual 
would more than likely still be in a range comparable with the euglycaemic condition 
of the diabetic group. However, to reduce the likelihood of any transient effect of 
elevated BGL, participants were advised to arrange a test session time approximately 
1-2hrs after their last main meal and to avoid the intake of high carbohydrate snacks 
or beverages within this window. 
Procedure 
All research sessions for the diabetic group were held at the Waikato Regional 
Diabetes Service (WRDS) as a diabetic nurse was required for the monitoring of BGL 
during testing. The non-diabetic test sessions were held on the University of Waikato 
campus. Research session time was approximately 1.5 to 2.5hrs per session for 
participants from both groups. Session length variability was contributed to by the 
speed of task administration and completion, as well as blood glucose manipulation 
for the diabetic group. 
Diabetic group. Eligible individuals were mailed information about and 
invited to participate in the study. The information informed potential participants 
they would be contacted in future by a research assistant and were provided contact 
details if they desired to make contact before then. As an additional recruitment 
measure, study information flyers were posted in the WRDS clinic and clinic nurses 
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were encouraged to discuss the study with any eligible patients presenting at the 
service. 
 Letters were followed-up within approximately two weeks of posting via a 
phone-call or text message by the research assistant. Individuals were asked if they 
had received the letter, and if they had any questions about the study. An appointment 
was made for a mutually convenient time for those who wished to participate. 
Research sessions. All research sessions were conducted prior to 12pm on 
weekdays, usually starting around 9am. In an effort to minimise BGL related down-
time, participants were contacted the night before their session to inform them of the 
condition they would be assigned to. Participants assigned to the euglycaemic 
condition were advised to take their insulin as per usual. 
 On arrival to the diabetes clinic, participants provided written consent to 
participate in the study prior to a research nurse obtaining biomedical data.  
Following the collection of biomedical information, the research nurse reported as to 
whether the participant’s BGL was in the required range for the assessment to begin. 
If BGL was found to be outside of the target range, the research nurse administered 
either insulin to reduce BGL or a high carbohydrate drink (Ensure Plus) to raise BGL. 
The required dose of either insulin or glucose was calculated by the diabetes nurse. 
BGL was then retested at approximately 15-30 minute intervals until within the 
required euglycaemic range, at which point the research session was able to proceed.  
 Prior to administration of psychometric measures, participants completed the 
demographic and background information questionnaire. During administration of 
psychometrics measures, BGL was monitored each hour. If it was found that BGL 
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had deviated outside of the euglycaemic range, testing was paused and BGL adjusted 
to within range before testing continued. Participants were informed that a diabetes 
nurse was available if at any time they should feel unwell during testing. Participants 
were also told they could take a break at any time during testing if required, however 
all participants completed the sessions without a break. 
  Following completion of all assessments, participants BGL was tested for a 
final time and (if required) adjusted to within the euglycaemic range before the 
participant left the clinic. Participants were thanked for their time, asked if they had 
any questions, and were given a $20 gift voucher as a gesture of appreciation. 
Control group. Participants typically volunteered for the study via email, and 
were subsequently provided with further information and a copy of the consent form 
(see Appendix B). Participants were offered the opportunity to ask any questions 
about the study prior to consenting to participate and were advised they could 
withdraw at any stage without penalty. Written consent to participate was provided by 
each participant either by email or at the commencement of assessment. For those 
wishing to participate, a mutually agreeable time to meet was arranged. At the 
conclusion of testing, participants were offered their choice of university course 
credit (2%) or a $20 gift voucher as a gesture of appreciation for their time.  
Research sessions. As control group participants were only tested on a single 
occasion, all relevant measures were completed in one session. The majority of 
research sessions were conducted on the University of Waikato campus, in a small 
research room. While not practical to measure BGL for this group, participants were 
advised to refrain from high carbohydrate snacks or beverages directly prior to the 
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testing session. One participant in the control group reported a history of traumatic 
brain injury and dyslexia and subsequently their results were excluded from analysis 
and another participant was recruited in their place. 
Statistical Analysis  
 Quantitative analysis of data was completed using SPSS software version 23. 
An alpha level of .05 (two-tailed) was used for all analyses. Before analysis, the 
distribution of the data was examined and non-parametric tests used where 
appropriate.  
 First the characteristics of the participants in the diabetic and control group 
were compared using independent samples t-tests (see Table 1, page 23). To compare 
the performance of the two groups on the cognitive and neuropsychological 
assessments, a series of between group ANOVAs were conducted. This was intended 
to compare diabetic to control group performance across the measures of EF. For the 
BRIEF only the three main indices were compared — the BRI, MI and GEC (see 
page 44). For the performance-based measures a subsequent series of ANCOVA 
analyses were performed using the WASI-II FSIQ as a covariate (see Table 5, page 
39).  
 For the BRIEF, where clinical cut-off scores were available (i.e., T-score over 
65), between group comparisons were made based on the number of participants over 
the cut-off on any of the three main indices. Due to low expected frequencies, a 
Fisher’s Exact Test was used for this comparison (see Table 6, page 45). Next, to 
explore the relationship between the performance-based measures of EF and the 
BRIEF, Spearman’s correlations were performed. For this analysis only the three 
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main indices of the BRIEF were used (see Table 7, page 47).  
 Additional analyses focussed solely on the diabetic group. Spearman’s 
correlations were conducted to examine the relationship between performance on all 
measures of EF and three diabetic related variables — HbA1c, age of diagnosis and 
time since diagnosis (see Table 8, page 49). Finally, Spearman’s correlations were 
then also performed to explore the relationship between average BGL over the course 
of assessment, and scores on the both the subscales and indices of the BRIEF (see 




The two primary aims of the current study were to explore differences between the 
diabetic and control group on the administered measures of EF, and to examine the 
relationship between diabetic related variables and EF in the diabetic sample.  
Performance-Based Measures of EF.  
Table 5 
Summary of Between-Groups Comparison of Scores on Performance-Based 













        (95% CI) Mean
a







       
 CWI  11.44 (9.71-13.16) 11.82 (10.09-13.55)    .10 .75 <.01 
 CWIS  11.33 (10.4-12.63) 11.76 (10.46-13.05)   .93 .34   .04 
 NLS  11.32 (10.48-12.16) 11.35 (10.51-12.20)   .25 .62   .01 
Cogstate         
 TCT 1.74 (1.60-1.88) 1.65 (1.51-1.80)   .25 .62   .01 
 GMLT  40.66 (31.05-50.26) 53.19 (43.58-62.79)   .30 .60   .01 
 GMLTDR  3.61 (1.99-5.23) 5.05 (3.49-6.61)   .04 .84 <.01 
 OBT 1.14 (.97-1.31) 1.32 (1.15-1.49) 1.27 .27   .05 
 TBT  1.18 (1.08-1.29) 1.22 (1.12-1.32) 2.39 .14   .09 
 SST 21.59 (17.02-26.17) 13.80 (9.22-18.37) 8.12 .01*   .25 
Note: ᵃ WASI-II full scale IQ was included as a covariate - adjusted means are presented. 
*significant at p<.05 level. CWI=Color-word inhibition; CWIS; Color-word inhibition 
switching; NLS=number-letter sequencing; TCT=Timed Chase Test (moves per second); 
GMLT = Groton Maze Learning Test (errors); GMLTDR; Groton Maze Learning Test - 
Delayed Recall (errors); OBT= One Back Test (reaction time); TBT=Two Back Test (accuracy); 




A summary of between-groups analyses on performance-based measures of 
EF are presented in Table 5. For reference, sample characteristics of the study groups 
are previously presented in Table 1 (page 23). Generally, all D-KEFS scores of the 
control group were on average higher (better) than the diabetic group, while on the 
Cogstate the diabetic group performed better than the control group on four of the six 
tests. 
A between-group series of ANOVA analyses found the diabetic and control 
group did not differ significantly on most measures (due to the relatedness of the 
dependent variables and comparatively small sample size, a MANOVA analysis was 
deemed inappropriate). As there is evidence to suggest IQ is related to performance-
based measures of EF (Friedman et al., 2006), an additional series of between-groups 
ANCOVAs using WASI-II full scale IQ as a covariate were performed — all tables 
and figures for the performance-based measures show adjusted means. 
 
Figure 1. Between-group comparisons of mean scaled score on D-KEFS subtest 
conditions including 95% confidence intervals, adjusted for IQ. Higher score 
indicates better performance. CWI= colour-word inhibition; CWIS= colour-word 





























Figure 1 provides illustrative comparison between groups on the D-KEFS 
tests of executive function.  While not significantly different (Table 5), the control 
group’s scaled scores were on average higher than that of the diabetic group, 
suggestive of a better performance. On the NLS task, the groups’ mean performance 
was virtually identical. 
 
 
Figure 2. Between group comparisons of mean scores on the Cogstate OBT and TBT 
including 95% confidence intervals, adjusted for IQ. OBT = One-Back Test, higher 
score indicates slower performance; TBT =Two-Back Test, higher score indicates 
more accurate performance. 
 
Figure 2 provides comparison of mean scores between groups on the Cogstate 
OBT and TBT, which measure speed and accuracy of working memory respectively. 
While not significantly different (Table 5), on the OBT the diabetic group were on 
average faster at responding than the control group, while on the TBT the diabetic 




























diabetic group demonstrated a faster reaction time, but with decreased accuracy in 




Figure 3. Between-group comparisons of mean moves per second on the Cogstate 
TCT including 95% confidence intervals, adjusted for IQ. TCT = Timed Chase Test, 
higher score indicates faster performance. 
 
Figure 3 shows the difference in speed measured in moves per second 
between groups on the Cogstate TCT.  While not significantly different (Table 5), the 
































Figure 4. Between group comparisons of mean number of errors committed on 
Cogstate GMLT, GMLTDR and SST including 95% confidence intervals, adjusted 
for IQ. Lower score indicates better performance. GMLT= Groton Maze Learning 
Test; GMLTDR= Groton Maze Learning Test - Delayed Recall; SST = Set-Shifting 
Test. 
 
Figure 4 illustrates between-group comparison of mean errors on the Cogstate 
GMLT, GMLTDR and the SST. On both Groton Maze tests the control group was 
found on average to commit more errors than the diabetic group. Initial ANOVA 
analyses (without controlling for IQ) found the between-group differences in GMLT 
mean scores to be significant, F(1,26) =4.24, p=.05, 
2
p  = .14 . Following inclusion of 
the covariate (WASI-II FSIQ), the difference between groups on this test failed to 
reach significance (Table 5). This finding suggests that variations in IQ are likely to 
account for the between-group differences observed on the GMLT. 
 For the SST, initial ANOVA analysis found the control group committed on 
average significantly less errors than the diabetic group, F(1,26)= 5.51, p=.03, 
2



























.18. After inclusion of the covariate this result remained significant (Table 5). The 
differences observed on the SST however do not appear related to variations in IQ 
and therefore may suggest that the diabetic group experienced greater difficulty than 
the control group with set-shifting ability. 
Self-Report Measure of EF.  
 The Behavioral Rating Scale of Executive Function Self-Report (BRIEF-SR) 
was used to provide a subjective measure of EF. The three primary BRIEF index 
scores examined for comparison were: Behavioral Regulation Index (BRI), 
Metacognition Index (MI) and Global Executive Composite (GEC). Figure 5 
illustrates a comparison of each group’s average performance on the three indices. 
Groups were remarkably similar in their performance on this measure, with the 
control group scoring marginally better on each index. 
 
Figure 5. Between group comparisons of mean scores on BRIEF Global Executive 
Composite (GEC), Metacognition Index (MI) and Behavioural Regulation Index 























To compare the groups’ performance, a series of between-group ANOVAs 
were completed. Given that the BRIEF index scores were unlikely to be significantly 
related to IQ (Hocking, Reeve, & Porter, 2015), no covariate was included in 
analysis. None of the differences were found to be significant — BRI F(1,26) = .002, 
p= .97 
2
p  = <.01, MI F(1,26) = .010, p=.91, 
2
p  = <.01, and GEC F(1,26) = .002, 
p=.97, 
2
p  =<.01. 
 
Table 6 
Between-Groups Comparison of Number of Participants with BRIEF Index T-
scores Exceeding Clinical Cut-Off  
 
Group   
Index Diabetic Control P Cramer’s V 
 n (% of Diabetic) n (% of Control)   
BRI  1 (7.1) 1 (7.1) 1.00 .000 
MI  2 (14.3) 1 (7.1) 1.00 .115 
GEC  1 (7.1) 0 (0) 1.00 .192 
Note: BRIEF = Behavioural Rating Inventory of Executive Function; BRI = Behavioural 
Regulation Index; MI = Metacognition Index; GEC= Global Executive Composite. FET= 
Fishers Exact Test – two sided.  
 
To further examine each group’s performance on the BRIEF, a comparison 
was made between the groups based on the number of participants whose T-score 
exceeded the clinical cut-off of 65 for the three primary indices (Table 6). For all 
indices a total of six participants were found to have scores exceeding the clinical cut-
off, with the diabetic group having twice the number of individuals (n=4) compared 
with the control group (n=2). Given the small total number of participants over the 
cut-off, a Fishers Exact Test (two-sided) was performed. The number of individuals 
exceeding the cut-off on the BRI, MI or GEC was not found to be significantly 
related to group type (p=1.00 for each index). This suggests that individuals in the 
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diabetic group were no more likely than those on the control group to score over the 
cut-off on the indices of the BRIEF, however the very small sample size suggests this 
result should be interpreted with caution. 
Summary 
 Between-groups analyses of results on the performance-based measures of EF 
found few significant differences. In general the control group performed better on 
the tasks of the D-KEFS while diabetic group performed better on the majority of 
Cogstate tests. After inclusion of IQ as a covariate, a significant difference was 
observed between groups on the Cogstate SST on which the diabetic group  
committed a greater average number of errors than the control group, potentially 
indicative of an impairment in set-shifting ability.  On the self-report measure of EF, 
the BRIEF-SR, no significant differences were observed between groups on any of 
the three primary indices —BRI, MI or GEC. While the diabetic group had more 
participants with index T-scores over the clinical cut-off of 65, it was found that this 
was not significantly related to group type.   
Relationships between Performance-Based and Subjective Measures of 
Executive Function 
 Correlations were conducted for the diabetic and control group separately 
to examine the relation between scores on the performance-based tests of EF and the 
three indices of the BRIEF (Table 7). Generally, stronger relationships between the 
BRIEF and performance-based measures were observed for the diabetic group in 
comparison to the control group. For many of the measures, directionality of the 
relationship was different within each group.  
While the majority of these relationships were not significant, this was an 
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unexpected pattern. For example, the Cogstate GMLT and GMLTDR errors were 
positively related to the BRI and MI T-score for the diabetic group however were 
negatively related to these same indices for the control group. This suggests greater 
impairment as measured by the BRIEF may be associated with more errors in 
learning and recall of the maze task for the diabetic but not control group. 
Table 7 
Correlations Between BRIEF Index T-scores and Performance-Based 




















CWI (SS) -.3 -.29 -.32 .17 -.03 .15 
CWIS (SS) -.16 -.42 -.46 .51 .19 .43 
NLS (SS) -.53 -.82** -.73** .15 -.31 -.04 
TCT (mps) -.36 -.09 -.38 .17 .10 .28 
GMLT (errors) .22 .29 .35 -.20 -.19 -.14 
GMLTDR (errors) .39 .42 .35 .00 -.15 .05 
OBT (reaction time) -.4 -.63* -.63* -.24 -.42 -.58* 
TBT (accuracy) -.35 -.20 -.29 -.18 .33 .19 
SST (errors) .01 .56* .36 -.61* -.57* -.54* 
Note: *p<.05, **p<.01 (2-tailed). CWI=color-word inhibition; CWIS; color-word inhibition 
switching; NLS=number-letter sequencing; TCT=Timed Chase Test; GMLT= Groton Maze 
Learning Test; GMLTDR; Groton Maze Learning Test - Delayed Recall; OBT= One-Back 
Test; TB=Two-Back Test; SST=Set-Shifting Test. SS=scaled score; mps=moves per second; 
BRI= Behavioral Regulation Index; MI = Metacognition Index; GEC = Global Executive 




Significant correlations. A Spearman’s rank-order correlation found that for 
the diabetic group, BRIEF MI T-score was negatively related to D-KEFS NLS scaled 
score and Cogstate OBT reaction time, while positively related to Cogstate SST 
errors. This result suggests that for the diabetic group, an increasing score on the MI 
(greater level of impairment) is associated with a worse performance on the NLS 
task, reduced speed on the OBT and a greater number of SST errors. Similarly to the 
MI, the GEC was also negatively related to NLS scaled score, and the OBT. 
 For the control group BRIEF BRI, MI and GEC T-score all significantly 
correlated with Cogstate SST errors. However converse to the diabetic group, this 
result suggests a higher BRIEF index score is associated with fewer Cogstate SST 
errors. The only other significant relationship observed was between GEC score and 
the OBT. Similar to the diabetic group, this suggests an increased GEC score is 
associated with reduced speed (increased reaction time) on the OBT. 
Relationship between Diabetic Related Variables and EF  
 The second primary aim of the current study was to examine the 
relationship between diabetic related variables and EF performance. This was 
intended to support the between-group comparisons by providing additional 
information about specific factors which may be affecting EF for the young adult 
with T1DM.  
 Spearman’s correlations were performed between three diabetic specific 
variables (HbA1c, age of diagnosis and time since diagnosis) and scores obtained on 
the performance-based measures of EF as well as the scales and indices of the 
BRIEF. No significant correlations were observed between any of the objective 
measures of EF and HbA1c, age of diagnosis or time since diagnosis. A summary of 
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the correlations between the BRIEF and diabetic related variables are presented in 
Table 8 (details of the composition of the BRIEF can be found in Table 3, page 30). 
Table 8 
Correlations Between HbA1c, Age of Diagnosis, Time Since Diagnosis and T-







rs rs rs 
Behavioural Regulation Index  .79*  -.27  .30 
 Inhibit  .65*  .11  -.03 
 Shift  .49  -.28  .18 
 Emotional  Control  .40  -.36  .39 
 Monitor  .71**  -.52  .53 
Metacognition Index  .31  .35  -.28 
 Working Memory  .30  .12  .04 
 Plan/organise  .26  .42  -.39 
 Organisation of materials  .46  .12  -.04 
 Task completion  .10  .26  -.24 
Global Executive Composite  .52  .12  -.05 
Note: *p<.05, **p<.01 (2-tailed). BRIEF=Behavior Rating Inventory of Executive 
Function 
  
 Generally a participant’s age of diagnosis negatively correlated with the 
BRI and most of its contributing subscales, while positively correlating with the 
subscales of the MI. In contrast, time since diagnosis demonstrated predominantly 
negative correlations with the MI and the subscales and positive correlations with the 
BRI and its scales. This suggests that an earlier the age of diagnosis and longer 
disease duration is associated with greater likelihood of impairment in the area of 
behavioural regulation, but lesser likelihood of difficulty in the area of metacognition 
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— namely planning, organisation and task completion. It should however be noted 
that this was just a general trend and no significant relationships were observed. 
  In general HbA1c was found to have relatively large (considering the 
small sample size) and exclusively positive correlations with all BRIEF subscales and 
indices. It was found that participants’ HbA1c was significantly related to scores on 
the BRI (rs=.79, p<.001), the ‘Inhibit’ scale (rs=.65, p=.012) and the ‘Monitor’ scale 
(rs=.71, p=.004). This suggests that an increase in HbA1c, which typically indicates 
poorer long-term glycaemic control, is associated with increasing impairment in the 
ability to inhibit impulsive responses and monitor one’s behaviour. No significant 
correlations were observed between HbA1c and the MI or its’ contributing subscales.  
Within session factors and EF performance. An important part of the study 
design was to ensure diabetic participants were assessed while in a euglycaemic state 
to limit any potential influence of transient BGLs on EF. While HbA1c reflects 
longer term glycaemic control, current BGL reflects a potential acute effect. To 
examine whether the minor variations in BGL while in the euglycaemic condition 
influenced participant’s EF performance, a Spearman’s correlation was performed 
comparing mean BGL with performance-based measures of EF which can be 
observed in Table 9. Correlations between the BRIEF scores and mean BGL were not 
calculated as this measure was not completed in the euglycaemic condition. 
 Generally participant’s D-KEFS scores were positively related to mean BGL 
suggesting higher average blood glucose improved performance on these tasks. 
Higher mean BGL was also related to improved performance on the majority of the 
Cogstate tests.  
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There was a significant positive relationship between mean BGL and 
participants’ scores on both the OBT and TBT of the Cogstate which relate to speed 
and accuracy of working memory respectively. This suggests that a participant with a 
higher average BGL during the assessment was more likely to have a slower reaction 
time on the OBT, but be more accurate in their decisions on the TBT. 
 
Table 9 
Correlations Between Mean Blood Glucose Level During 
Assessment and Scores on Performance-Based Measures of EF 
for the Diabetic Group (n=14) 




D-KEFS (SS)   
 
 CWI  .24 
 CWIS  .22 
 NLS  .50 
Cogstate   
 TCT (mps)  .51 
 GMLT (errors)  -.20 
 GMLTDR (errors)  -.26 
 OBT (reaction time)  .59* 
 TBT (accuracy)  .54* 
 SST (errors)  -.39 
Note: *p<.05, **p<.01 (2-tailed). CWI=color-word inhibition; CWIS; 
color-word inhibition switching; NLS=number-letter sequencing; 
TCT=Timed Chase Test; GMLT = Groton Maze Learning Test; GMLTDR= 
Groton Maze Learning Test - Delayed Recall; OBT= One-Back Test; 
TBT=Two-Back Test; SST=Set-Shifting Test. SS=scaled score; mps=moves 




Summary of Results 
Between-groups analyses of results on the performance-based measures of EF 
found few significant differences between the groups. Generally the control group 
performed better on the tasks of the D-KEFS, while on the Cogstate the diabetic 
group performed better on the majority of tests. A significant difference was observed 
between groups on the Cogstate SST on which the diabetic group on average 
committed more errors than the control group, which may indicate impairment in set-
shifting ability. For the BRIEF, group’s performance was remarkably similar with no 
significant differences observed between groups on any of the three primary indices 
—BRI, MI or GEC. 
 Correlational analysis between the performance-based measures of EF 
and the BRIEF found patterns unique to each group. While the majority of 
relationships were not significant, generally stronger correlations were observed 
between measures for the diabetic group. Within the diabetic group a higher (greater 
impairment) BRIEF MI score was significantly and at least moderately associated 
with a worse performance on the D-KEFS NLS task, reduced speed on the Cogstate 
OBT and a greater number of errors on the SST. Similar significant relationships 
were also found between the BRIEF GEC and the NLS and the OBT.  
 For the control group BRI, MI and GEC were significantly and 
moderately related to Cogstate SST errors, however converse to the diabetic group a 
higher BRIEF index score was associated with less as opposed to more errors. Similar 
to the diabetic group, a moderate and significant relationship was observed between 
GEC score and the Cogstate OBT suggesting increasing impairment as measured by 
the BRIEF was associated with reduced speed of working memory. 
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Further analysis focussed solely on the diabetic group to examine the 
relationship between diabetic related variables and measures of EF. Several 
significant correlations were observed for the BRIEF, but none were found for 
performance-based measures of EF. Most notable was the positive relationship 
between HbA1c and the scores on the BRI index, and the ‘inhibit’ and ‘monitor’ 
subscales, suggesting poor glycaemic management is potentially associated with 
impairments in the ability to inhibit impulsive responses and monitor one’s 
behaviour. It was also found that participants’ mean BGL during assessment was 
significantly related to performance on the OBT and TBT of the Cogstate which 
measure speed and accuracy of working memory respectively. This meant a higher 
mean BGL was associated with reduced speed on the OBT but increased accuracy on 






This study investigated the effect of T1DM on EF in a sample of young adults, using 
an age and gender matched control group for comparison. This was achieved by 
recruiting both diabetic and non-diabetic participants and administering subjective 
and performance-based measures of EF to both groups. Given that diabetes is 
primarily a disease of insulin and glucose dysregulation, attempts were made to keep 
the BGL of the diabetic group within a normal or euglycaemic range for the duration 
of testing. 
The study had two primary aims: to identify any differences on measures of 
EF between a diabetic and non-diabetic sample of young adults, and to examine any 
relationship between diabetic related variables and scores on measures of EF. There 
has been limited previous research specifically looking at the effect of T1DM on EF 
in this age range. Young adulthood represents a unique developmental period in 
which healthy and robust executive functioning is essential to navigate many 
significant new risks and responsibilities, and which may influence one’s future 
health, educational and vocational outcomes.  
The primary analysis of the study was to compare each group’s scores on the 
measures of EF. For the performance-based measures, WASI-II full scale IQ was 
included as a covariate to help reduce the effect of IQ. It was found that the groups 
did not differ significantly on most of the administered measures. The exception to 
this was the Cogstate SST, on which the diabetic group performed more poorly, 
demonstrated by a greater average number of errors.  This result is consistent with the 
study by Ly et al. (2011), in which it was found a sample of young adults with T1DM 
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committed more perseverative errors on the Wisconsin Card Sorting Test (WCST), 
than a healthy matched control group. The WCST is similar to the SST in that they 
both require the participant to learn and apply a rule in response to feedback.  
Interestingly, the diabetic sample used by Ly et al. (2011) all experienced 
early-onset diabetes, with a mean age of diagnosis of 3.3 years, and mean disease 
duration of 16 years. Given that disease duration has been associated with increasing 
impairments in EF (Desrocher & Rovet, 2004), it would follow that a young adult 
diagnosed early in life may be more likely to show impairment in EF than an 
equivalent peer with a more recent diagnosis. 
 In the current study, mean age of diagnosis was 11.3 years with only two 
participants receiving a diagnosis before the age of five. This suggests that the group 
differences observed in set-shifting ability may be independent of disease duration, 
and may represent a unique neurocognitive impairment associated with disease 
pathology. This assertion is tentatively supported by the lack of any significant 
relationship between disease duration and diabetic participant scores on the SST.   
The D-KEFs NLS task is also considered a measure of set-shifting, requiring 
the participant to switch between alternating stimuli to complete a sequence. Like the 
WCST, the NLS task is believed to activate similar cortical structures — the 
dorsolateral and medial PFC (Riehemann et al., 2001; Zakzanis, Mraz, & Graham, 
2005). However, unlike the SST, the groups did not differ significantly on this task. 
Several possible explanations could account for this.  
It is possible that the set-shifting test of the Cogstate and the NLS task are not 
equivalent measures of set-shifting ability. On face value, the former is a 
computerised task while NLS is pen and paper based. The NLS requires the 
 56 
individual to alternate between different stimuli under a fixed-rule condition —that is 
they must alternate between number and letter in ascending order, while the Cogstate 
test requires a change of response dependent on schedules of reinforcement —that is 
the participant’s correct response produces a new card, or the card remains and an 
error-sound signals that they must determine the new target card via trial and error.  
Latzman and Markon (2010) make an interesting assertion in their factor 
analysis of the D-KEFS structure, finding that the NLS task loaded most strongly on 
the ‘inhibition’ factor. That is the individual must inhibit the prepotent response of 
completing the respective category in order (numbers or letters) to accurately 
complete the task. They must also be able to recall numbers and letters from long-
term memory, while keeping track of where they are in the sequence, drawing on 
working memory ability (SÁNchez-Cubillo et al., 2009) and rely on visual-motor 
ability. Considering Miyake et al. (2000) proposed core EFs: shifting, inhibition and 
updating of working memory — the NLS could be considered a test of all these 
domains.  
The primary outcome measure of the NLS is completion time, which is 
converted to a scaled score, while the Cogstate SST measures errors. The extent to 
which NLS errors affect completion time is dependent on the examinee noticing the 
error or the examiner providing a prompt to make a correction. Given that the study 
sample rarely committed errors on the NLS task, it is possible that task requirements 
other than ‘shifting’ exerted greater influence on completion time; or that it is a least 
difficult to quantify how an individual’s set-shifting ability specifically contributed to 
their NLS score.  
As the Cogstate task does not appear to place similar demands on working 
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memory or inhibition, it could be posited that it is a more accurate reflection of set-
shifting ability. It is possible that if the NLS task was more complex, or if the study 
population was less functional (a lower mean IQ for example) that between-group 
differences would have been observed on this task also.  
It should be noted that an important limitation to findings on the Cogstate SST 
was the difficulty observed in some participant’s comprehension of test requirements. 
A number of participants reported they did not understand the instructions of the task, 
even after repeated explanation. It is possible that some participants were responding 
at random, rather than in accordance with the task instructions. This potential 
inconsistency is undesirable, however it should be considered that both groups 
received the same instructions, and difficulty understanding the task was not only a 
diabetic group anomaly, which may have exerted some balancing effect.  
While there were no other between-group scores that were significantly 
different, a general trend was that the control group on average performed better on 
the tests of the D-KEFS, while the measures of the Cogstate provided mixed results. 
Interestingly the diabetic group performed better on the Cogstate maze learning and 
delayed-recall tests.  
The GMLT is broadly categorised as a general measure of EF; the participant 
is required to find the same hidden pathway over a number of trials in response to 
trial and error feedback while following the rules of the maze. The primary outcome 
measure is total number of errors. Delayed-recall of this pathway is considered 
primarily an assessment of spatial memory, and is also measured by total errors. It 
would be difficult to explain why the diabetic group would be better at these tasks, 
and more than likely the trend is attributable to sample variation. It is however worth 
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noting that in the meta-analysis examining diabetes and T1DM by Brands et al. 
(2005), it was found that the domains related to learning and memory showed 
relatively small impairment in individuals with T1DM, and did not differ 
significantly from non-diabetic controls. It is also relevant that in the absence of poor 
glycaemic control, any potential cognitive decline associated with T1DM may be 
modest even over long disease duration (Jacobson et al., 2011). Given the relative 
youth and high level of functioning of the current study sample, it is especially 
unlikely that between-group differences would be observed on cognitive domains not 
highly sensitive to diabetes. 
On the Cogstate OBT and TBT, which are considered primarily tasks of 
working memory, the diabetic group on average appeared to respond faster (OBT) but 
with decreased accuracy (TBT). This may be indicative of a more impulsive response 
style which also could reflect poorer inhibitory processes. As previously mentioned, 
while not significantly different, the control group on average performed better than 
the diabetic group on the measures of the DKEFS, all of which place demands on 
inhibitory control. This may suggest that there was greater impairment in inhibition 
for the diabetic group.  
Jasinska et al. (2012) found that impulsivity and poor inhibitory control were 
associated with increases in unhealthy eating in young adults — a pertinent finding 
given the demands placed on diabetic individuals to monitor and modulate their 
glycaemic intake. Poor inhibitory control is also associated with decreased academic 
performance (Garner, 2009), which is also relevant given that many of the study 
demographic are still enrolled in education.   
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Interestingly, inhibitory control appears to have limited specific research in 
diabetes literature, aside from the specific influence of variation in acute blood 
glucose levels (e.g.,Graveling, Deary, & Frier, 2013). A study by Rovet and Alvarez 
(1997) which focussed on attentional processes, found no significant difference 
between type 1 diabetic children and adolescents and a matched control group on a 
computer based task of inhibition. However a subset of the diabetic group who had 
experienced a history of at least one seizure following hypoglycaemia, performed 
significantly worse than the control group on the same task.  
Ishizawa, Kumano, Sato, Sakura, and Iwamoto (2010) found impaired 
response inhibition compared to healthy controls in a sample of middle-aged type two 
diabetics as assessed by a Go/NoGo task of inhibition. It is however unclear if this 
pattern would be the same in young adults with T1DM (Kodl & Seaquist, 2008) and 
the inhibitory components assessed by the Go/NoGo and those of the D-KEFS 
(specifically the CWIT) may have limited commonality (Morooka et al., 2012). A 
more thorough investigation into the specific components of inhibition potentially 
affected by T1DM could be a useful avenue for further research. 
Given the BRIEF is a subjective, questionnaire-format assessment, it was 
considered useful to examine how this correlated with the D-KEFS and Cogstate to 
compare and contrast a behavioural rating scale with performance-based measures for 
each group. The most salient of the observed relationships are discussed below. In 
general the results were quite varied, with some inconsistent and unusual differences 
between groups which likely reflected the small study sample. 
An interesting finding was the significant correlation between D-KEFS NLS 
task and the BRIEF MI and GEC, which shared a strong negative relationship in the 
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diabetic group but was more weakly and not significantly in the control group. This 
suggests for the diabetic group, poorer performance on the NLS task (set-shifting) 
was related to increasing impairments in overall executive function as measured by 
the BRIEF. This finding is unusual in that a number of studies have generally found 
little correlation between the BRIEF and performance- based measures of EF in other 
(non-diabetic) clinical populations (e.g.,V. A. Anderson, Anderson, Northam, Jacobs, 
& Mikiewicz, 2002; McAuley, Chen, Goos, Schachar, & Crosbie, 2010; Vriezen & 
Pigott, 2002). 
 Toplak, West, and Stanovich (2013) suggest that in general “performance-
based measures of executive function provide important information regarding 
efficiency of processing, but ratings of executive function tell us more about success 
in rational goal pursuit” (p.138). This statement is supported by McAuley et al. 
(2010) who found that the BRIEF correlated well with reported behavioural 
disruption and impairment but not any performance-based measure of EF — 
suggesting the true value of the BRIEF may in part lie in its’ ecological validity. 
While the NLS is considered a measure of set-shifting ability, the MI 
primarily purports to measure one’s ability to plan, organise and complete tasks. 
Given that a central cognitive skill associated with set-shifting is problem solving 
(Suchy, 2009), which is also essential for good diabetes management (Glasgow, 
Toobert, Barrera, & Strycker, 2004) — it is possible that in the current diabetic 
population, impairments on the NLS and MI may both be related to problem-solving 
ability. This may in turn facilitate poor diabetes management and increase the 
likelihood of future impairment.  
A study by Mitchell and Miller (2008) found that in a sample of community-
 61 
dwelling older adults, the NLS task was the best predictor of functional status among 
four D-KEFS tests employed. While this is a considerably different population, it 
suggests that there is a precedent for relatedness of the NLS and a more functionally 
relevant measure such as the BRIEF.   
It should be noted that as previously discussed, the NLS task is likely not a 
‘process-pure’ assessment of set-shifting ability. However the Cogstate SST also 
shared significant yet opposing relationships with the MI for each group. This was 
again unusual but further supports the notion that increased impairments in set-
shifting may be related to functional impairments as measured by the BRIEF in a 
diabetic sample. 
In summary, within a diabetic population a rating scale such as the BRIEF 
may hold more ecological validity than a performance-based measure, but may also 
provide information about underlying executive processes. The NLS task or similar 
trail-making tests may correlate with behavioural or functional outcomes as a result 
of impairments in problem-solving ability. Further research with a larger study 
population may be useful to understand this relationship further. 
Analysis solely focussed on the diabetic group data provided some insight 
into other diabetic specific variables related to EF. Most notable was the relationship 
between HbA1C, a measure of longer term (2-3 months) glycaemic control and the 
BRIEF, namely the BRI, and the ‘Inhibit’ and ‘Monitor’ subscales. Broadly speaking, 
the BRI purports to measure attentional, inhibitory and emotional components of EF 
employed when modulating behaviour.  That this relationship exists is unsurprising as 
one likely needs considerable behavioural control to effectively engage in the self-
care required to manage diabetes, and is not a unique finding (e.g.,Bagner, Williams, 
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Geffken, Silverstein, & Storch, 2007; McNally, Rohan, Pendley, Delamater, & 
Drotar, 2010). It is however unclear the causal direction, and if elevated BRI scores 
would be reduced if adequate glycaemic control was restored.  
Interestingly, there was no significant relationship between any performance-
based measure and HbA1C, however this is consistent with the findings of Suchy et 
al. (2016) who also used measures of the D-KEFS in a sample of late adolescents 
with T1DM. This may again reflect differences in the processes being measured. 
 Another possibility is that broadly speaking the BRIEF, in particular the BRI, 
is more of a measure of so-called ‘hot’ EFs. That is those EFs related to “stimuli, 
decisions, and outcomes that are motivationally salient” (Prencipe et al., 2011, p. 
622). It is possible that these hot executive processes are more closely related to and 
influenced by longer term glycaemic control than the ‘cool’ or abstract problem-
solving EFs of the performance-based measures. Hot executive processes are 
suggested to be employed in affective decision-making, delayed gratification, and 
impulse control and have been found to exhibit a relationship with eating style and 
weight gain (Groppe & Elsner, 2015). 
These findings may hold relevance for diabetes self-care by tentatively 
suggesting that hot EFs may be particularly vulnerable to poor glycaemic control as 
evidenced by elevated HbA1C, which in turn can impact patterns of eating and affect-
based decision making. Alternatively, impairments in hot EFs may lead to poorer 
diabetes management and thus higher HbA1c. This is consistent with research by 
Stupiansky, Hanna, Slaven, Weaver, and Fortenberry (2013) who found that poor 
impulse-control was associated with poor diabetes management. Given that hot EFs 
may exhibit a longer developmental time frame than cool EFs (Prencipe et al., 2011), 
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younger adolescents may be at greater risk of poorly managing their diabetes. The 
current findings also support the assertion by McNally et al. (2010) that measures of 
EF may have some additional utility in diabetes management. Future research may 
benefit from focussing on a potential mediational role of hot executive processes in 
the context of diabetes self-care. 
While not significant, a general trend was that the younger a participant was 
diagnosed the higher (greater impairment) they scored on the BRI while an older 
diagnosis was associated with a higher MI score. As might be expected, disease 
duration showed the inverse of this relationship, negatively correlating with the MI 
and positively correlating with the BRI.   
As disease duration, like HbA1c, is also associated with greater impairment 
on the BRI, this relationship may allude to hot executive process involvement also —
possibly hot EFs are more prone to the longer term effects of diabetes. However, 
other variables such as the unique psychosocial pressures on a child with T1DM, and 
the complex relationship between diabetes management and parenting practice 
(Young, Lord, Patel, Gruhn, & Jaser, 2014) suggests that this association may be 
much more complex.  
Given that the MI purports to measure those components of EF primarily 
relating to planning, organisation and task completion, it may follow that a longer 
history of managing diabetes means an individual has developed more aptitude in 
these areas. However like the relationship with the BRI, it is likely that a simplistic 
explanation is insufficient.  
A final area of interest to the current study was exploring relationships 
between mean BGL and participants’ scores on all measures. A participant’s mean 
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BGL was derived from the multiple readings taken throughout the assessment 
process. Given the attempts to maintain blood glucose within a euglycaemic range it 
was surprising to see that minor variations in acute blood glucose demonstrated a 
significant relationship with the Cogstate OBT and TBT. These tasks assert to 
measure working memory processes, namely speed and accuracy respectively.  
It has been well documented that acute BGL is related to cognitive 
performance in several domains (e.g.,Cox, Kovatchev, Gonder-Frederick, & 
Summers, 2005; Graveling et al., 2013), however the current findings suggest that 
certain areas of EF may be particularly sensitive.  A recent study by Hawkins, 
Gunstad, Calvo, and Spitznagel (2016), found that even among a sample of healthy 
young adults tested within a ‘normal’ BGL range, higher blood glucose was 
associated with poorer inhibitory control. While the Cogstate tests in discussion are 
more related to working memory than inhibition, a larger question remains as to the 
sensitivity of EF in general to subtle changes in acute blood glucose levels —and to 
what extent this may have also exerted influence on the control group performances. 
 Interestingly, the Cogstate findings suggest that increasing mean BGL was 
associated with slower but more accurate working memory processes. This is 
potentially indicative of a speed-accuracy trade-off which is also associated with later 
disease onset (Desrocher & Rovet, 2004). Another contributing factor could be an 
attentional lag, which is a residual impairment in attention observed by Rovet and 
Alvarez (1997) that occurs when a diabetic individual returns to a euglycaemic state. 
This may mean for those individuals presenting at the test session with a high BGL 
(and likely recording a higher mean BGL), a residual impairment in attention may 
have encouraged a more cautious response style.  
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These findings hold several implications for future research. Firstly that minor 
variations in BGL may influence EF, even in healthy controls. It may be useful to 
collect blood glucose data from any control group, and to control for BGL in analysis. 
It would also be preferable to ensure adequate time in a euglycaemic state for any 
diabetic individual prior to assessment to allow for any latency in post-
hyperglycaemic cognitive function.  
Study Limitations and Considerations  
The current study experienced a number of limitations, the most central of 
which are discussed below. Likely the most salient limitation was the small sample 
size which made meaningful interpretation of data difficult and conclusions tentative 
at best. This was primarily a reflection of the difficulty in recruiting a young adult 
clinical population. Potential participants were often difficult to contact, would fail to 
return contact and several failed to attend scheduled research appointments. Many of 
the study population reported difficulty finding time to attend appointments due to 
other commitments or a lack of suitable transport. This was partly a function of a lack 
of flexibility in the testing schedule and testing location. All research appointments 
were held at the WRDS, before 12pm, and only on certain weekdays as required for 
ethical approval. It is also possible given the relatively long time commitment per 
session (up to four hours), there was insufficient incentive for young people to attend. 
The difficulty in recruitment also suggests that it is likely that the study group 
were not a representative sample, meaning the selection process favoured those who 
were willing and had resources to invest (i.e., time, money, transportation). It is 
possible this was evidenced in the relatively high estimated IQ of the sample, 
suggesting a greater than average level of functioning. While the control group were 
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relatively well matched on IQ, it would have been interesting to include a more 
diverse and potentially more representative diabetic sample. It is also of note that a 
disproportionate number of diabetic participants were male. It is unclear why this was 
the case given that T1DM is only slightly more common in males. It is possible that if 
a larger sample had been recruited there would have been a more even gender 
balance.  
Future studies may benefit from streamlining the assessment procedure, 
providing a more flexible testing schedule (e.g., after hours, weekends) and 
potentially using other platforms for communication (e.g., social media) to connect 
with a young adult population and encourage more equal gender participation. 
Given the functional level of the study population, it is unclear whether all the 
measures used in the current study possessed suitable sensitivity to minor variations 
in EF. In particular the measures of the D-KEFS, which are pen and paper based and 
require accurate timing by the examiner, allow some room for testing discrepancy. 
Given that most young adults are completing the measures relatively fast and with 
few errors (compared for example to older adult population), small variations in 
completion time may hold greater significance — and any examiner errors more 
influential. A study of the D-KEFS by Keifer and Tranel (2013) also raised concerns 
about the sensitivity of the D-KEFS in detecting subtle executive dysfunction, 
suggesting the measure has a low floor and high ceiling with insufficient items of 
medium difficulty. 
By comparison the Cogstate records results automatically placing less reliance 
on the examiner, and has been found to correlate well with more traditional 
neuropsychological tests (Maruff et al., 2009). Given the likelihood that many young 
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adults are frequently engaged with media devices, future research may benefit from 
continuing to find ways to use computerised platforms for test administration with 
this population. 
A final and pertinent methodological consideration is the difficulty of 
consistently defining EF. According to Baggetta and Alexander (2016), a meta-
analysis yielded the conclusion that EF is one of the most widely cited yet confusing 
cognitive constructs.  This fact became more apparent throughout the duration of the 
current study, and suggests a more narrow focus potentially looking at a specific 
component of EF may have aided in maintaining conceptual clarity. 
Summary  
The current study sought to better understand the relationship between T1DM 
and EF in a sample of young adults. Few differences were observed between the 
diabetic and control group on the measures of EF used — only on the Cogstate SST 
did the control group significantly outperform the diabetic group, however this result 
was brought into question by difficulties in task comprehension. In general however 
the control group performed better on the majority of tasks of EF than the diabetic 
group — a larger sample size would be required to explore this trend more 
definitively.  
Along with set-shifting, there was some evidence the diabetic group may also 
have more difficulty with inhibitory control, impulsivity and problem-solving ability 
which may have implications for patterns of eating, risk-taking behaviour and overall 
diabetes management.  
In examining the diabetic group it was found that subtle changes in BGL, within 
the euglycaemic range, may have an impact on certain EFs, which may suggest that 
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tighter glycaemic control is required for both diabetic and control groups when trying 
to isolate the effects of T1DM on EF. It was also proposed that hot executive 
processes may interact with HbA1c and play a part in diabetes management.  
While not significant, disease duration was associated with poorer BRI scores on 
the BRIEF, but a better MI score. It was posited that this relationship may be subject 
to a complex range of psychosocial influences. It was found that the BRIEF shared a 
significant relationship with both HbA1c and several performance-based measures of 
EF, suggesting that the BRIEF may have useful ecological validity in a diabetic 
population, and be of value in diabetes management.  
While a number of limitations made it hard to draw definitive conclusions, the 
current study findings tentatively suggests that in a young adult population there is 
some evidence that the presence of T1DM is related to impairments in certain areas 
of EF — including set-shifting, inhibition and the higher-level construct of problem-
solving ability. There is also some evidence that in this population the diabetic-
related variable HbA1c shares a relationship with EF as measured by the BRIEF, but 
not with performance-based measures of EF. Future research suggestions for this 
population included: specifically examining the EF of inhibition; further examination 
of the relationship between the NLS task (trail-making) and the BRIEF; the role of 
hot EF in diabetes self-care, and the sensitivity of specific EF to subtle changes in 
BGL within a euglycaemic range.  
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